ADAR1 Capital Management »

Altimmune shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $313k 103k 3.04
2023-12-31 $44k 3.9k 11.25

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Altimmune

BlackRock
Deep Track Capital
TCG Crossover Management
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Marshall Wace
Viking Global Investors
RA Capital Management
Geode Capital Management
Woodline Partners
Millennium Management
Susquehanna International
Trails Edge Capital Partners
Nuveen

View all funds holding Altimmune